Anti-rejection Drugs Can Reduce Spinal Cord Injuries

This article examines Anti-rejection Drugs Can Reduce Spinal Cord Injuries. It presents the main facts, practical implications, and key points in a clearer, easier-to-follow format.

Understanding Anti-rejection Drugs Can Reduce Spinal Cord Injuries

A new study in mice showed that a drug commonly used to prevent graft rejection after transplantation called Rapamycin may also help reduce tissue damage and neuropathic pain in spinal cord injuries.

In addition, the drug Rapamycin is an effective inhibitor of mammalian body, regulating sugar (mTOR) and even immunity, even against dangerous tumors.

In a recent study at Tohoku Medicine University in Japan, experts found that Rapamycin may also help reduce nerve damage, movement disorders, chronic pain after an injury. spinal cord.

To find out, scientists took a mouse sample with spinal cord injury after being crushed in the chest and conducted Rapamycin injections for treatment, followed by monitoring the reaction of the drug.

Rapamycin drug promises to promote dual-use medicine in the future. Photo source: internet.

Unexpectedly, after 4 hours of injecting Rapamycin treatment, the spinal cord injury of the mouse was significantly improved, the motor function was gradually restored, reducing the phenomenon of chronic pain in mice.

Currently, the scientific group is continuing to study the preparation of Rapamycin, so that in addition to Rapamycin anti-rejection, it can also work to treat spinal cord injury right on the human body.

And if the drug actually works in the same way on the human body, Rapamycin certainly opens a new era, a new dose for patients with chronic spinal cord injuries.

This new finding is published in the Journal of Orthopedic Research.